A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Financial Summary
| Share Statistics | SLBT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,875.4 | $288.9 | 53% |
|
| Shares Out (Mil) | 3.7 | 54.0 | 11% |
|
| Institutional Ownership | na | 93.1% | na |
|
| Float (Mil) | na | 41.4 | na |
|
| Beta | na | 0.94 | na |
|
| Avg Daily Volume (000s) | 44 | 480 | 28% |
|
| Price Change (52-week) |
na | 59.9% | na |
|
| Growth | SLBT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 14.1% | na |
|
| Net Income (5yr) | na | (10.1%) | na |
|
| EPS (5yr) | na | 15.9% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | SLBT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3 | $37 | 4% |
|
| Net Income (TTM) (Mil) | ($2) | ($43) | 36% |
|
| EPS (TTM) | ($0.645) | ($1.500) | 25% |
|
| Operating Cash Flow (TTM) (Mil) | ($3) | ($31) | 27% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 12% |
|
| Enterprise Value (Q1) (Mil) | $1,508 | $190 | 45% |
|
| Valuation | SLBT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.57 | 2.84 | 59% |
|
| P/E | na | 20.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | SLBT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 38.4% | 66.9% | 48% |
|
| Net Margin | (72.5%) | (74.2%) | 9% |
|
| ROA | (81.8%) | (47.7%) | 7% |
|
| ROE | (100.2%) | (55.0%) | 9% |
|
| Liabilities to Assets | 18.3% | 29.6% | 12% |
|
| F-Score | 0 | 3 | na |
|
SL Science Holding Limited did not pass any screens on 9/2/2026.
